Literature DB >> 1734585

[High-dose-rate brachytherapy of prostatic carcinoma with iridium 192].

J U Schwarzer1, R Hofmann, P Kneschaurek, P Lukas, A Lindner, J Braun.   

Abstract

In the therapy of localized prostatic cancer the radical prostatectomy shows good results within a five-year interval with no evidence of disease in nearly 90%. An important alternative is the radiotherapy by external beam or interstitial technique with iodine, gold or iridium. We use the high dose rate technique with Ir-192. In this technique five to seven hollow needles are placed in the prostate from perineal punctures under transrectal sonographic control. The three-dimensional brachytherapy planning is done according the actual needle position. A computer program calculates the radiation dose and distribution for each needle by adjustment of time and stops of the Ir-implants. The Ir-192 is temporary loaded twice with 9 Gy supplemented with external beam radiation (18 x 2 Gy). Since 1985 29 patients with localized tumor (T1-T3, N0, M0) have been irradiated. 21/29 had a pelvic lymphadenectomy before. In 85% of the patients were seen no side effects. Only one patient had a serious complication through a recto-vesical fistula. Out of the 21 followed-up patients 16 were in full remission, three had an androgen deprivation because of progression. A local tumor control could be demonstrated by cytology in 70% of the patients. This rational technique seems to be an alternative for patients not eligible for a radical prostatectomy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1734585

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  3 in total

1.  [High-dose rate brachytherapy for high-risk prostate cancer].

Authors:  M Schenck; K Krause; R Schwandtner; I Haase; D Fluehs; J Friedrich; T Jaeger; C Boergermann; H Ruebben; M Stuschke
Journal:  Urologe A       Date:  2006-06       Impact factor: 0.639

2.  Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate.

Authors:  G J Van Leenders; H P Beerlage; E T Ruijter; J J de la Rosette; C A van de Kaa
Journal:  J Clin Pathol       Date:  2000-05       Impact factor: 3.411

3.  Iridium 192 high-dose-rate brachytherapy--a useful alternative therapy for localized prostate cancer?

Authors:  R Paul; R Hofmann; J U Schwarzer; R Stepan; H J Feldmann; P Kneschaurek; M Molls; R Hartung
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.